Use of third-generation cephalosporins. Anaerobes

R L Nichols1, J W Smith

  • 1Department of Surgery, Tulane University School of Medicine, New Orleans.

Hospital Practice (Office Ed.)
|January 1, 1991
PubMed

Insights

Third-generation cephalosporins offer broad-spectrum activity, effective for mixed aerobic-anaerobic infections and prophylaxis. Clinical use shows they can replace combination therapy in polymicrobial infections.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Third-generation cephalosporins exhibit enhanced activity against Gram-negative bacteria.
  • They possess moderate activity against anaerobic bacteria but reduced activity against Gram-positive bacteria compared to earlier generations.

Purpose of the Study:

  • To evaluate the clinical utility of third-generation cephalosporins for treating mixed aerobic-anaerobic infections.
  • To assess their role in prophylaxis for patients with expected mixed flora.
  • To analyze the correlation between in vitro susceptibility and clinical efficacy.

Main Methods:

  • In vitro testing of anaerobic bacteria susceptibility using various methods, including microtube broth dilution.
  • Review of clinical studies on the use of third-generation cephalosporins in polymicrobial infections and prophylaxis.

Main Results:

  • In vitro susceptibility of anaerobes is method-dependent, with regional variations observed.
  • The microtube broth dilution method demonstrated the best correlation with in vivo results.
  • Clinical efficacy does not always align with in vitro susceptibility or resistance patterns.

Conclusions:

  • Third-generation cephalosporins are suitable for monotherapy in mixed aerobic-anaerobic infections.
  • They can be used as prophylaxis when mixed microflora are anticipated.
  • These agents may serve as alternatives to combination therapy for polymicrobial infections.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...